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Abstract
Human neurons express the innate immune response receptor, Toll-like receptor 3 (TLR3). TLR3 levels are increased in
pathological conditions such as brain virus infection. Here, we further investigated the production, cellular localisation, and
functionofneuronalTLR3duringneuronotropicrabiesvirus(RABV)infectioninhumanneuronalcells.FollowingRABVinfection,
TLR3 is not only present in endosomes, as observed in the absence of infection, but also in detergent-resistant perinuclear
inclusion bodies. As well as TLR3, these inclusion bodies contain the viral genome and viral proteins (N and P, but not G). The
size and composition of inclusion bodies and the absence of a surrounding membrane, as shown by electron microscopy,
suggest they correspond to the previously described Negri Bodies (NBs). NBs are not formed in the absence of TLR3, and
TLR3
2/2 mice—in which brain tissue was less severely infected—had a better survival rate than WT mice. These observations
demonstrate that TLR3 is a major molecule involved in the spatial arrangement of RABV–induced NBs and viral replication. This
study shows how viruses can exploit cellular proteins and compartmentalisation for their own benefit.
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Introduction
Toll-like receptors (TLR) are innate immune receptors that
recognise and respond to the presence of PAMPS (pathogen
associated molecular patterns) encoded by pathogens [1]. TLR3 is
a type I intracellular transmembrane protein that contains a large
leucine-rich repeat (LRR) in the extracellular region and a Toll/Il-
1 receptor homology (TIR) signalling domain in its cytoplasmic
region. TLR3 can detect the presence of and respond to
exogenous and endogenous RNA molecules: dsRNA of viral
origin, mimicked by polyriboinosine-polyribocytidylic acid
(polyI:C); mRNA; and ssRNA (polyinosinic acid) [2,3,4]. Upon
ligand binding, TLR3 signals via a MyD88-independent signalling
pathway involving the adaptor molecule TRIF/Ticam-1 [5,6].
TRIF can induce activation of IRF3 and NF-kB, notably through
the interaction with TRAF6 and RIP1 [7,8,9,10,11,12,13,14].
TLR3-dependent activation leads to the expression of genes
encoding proinflammatory cytokines, chemokines and IFN-a/b.
TLR3 is present within the central nervous system (CNS) [2].
High levels of TLR3 are found in glial cells [15,16] and neurons in
disorders of the brain, neurodegenerative diseases and viral
infections [17,18]. The high levels of TLR3 in the CNS suggests
an important role in the response to neuronal injury and/or viral
infection [19], which may involve mechanisms other than those
limited to the innate immune response. Indeed, TLR3 has been
described as a negative regulator of axonal growth [20].
In non-neuronal cells (dendritic cells (DCs) or epithelial cells),
TLR3 is found in intracellular compartments — sometimes small
perinuclear structures (300–500 nm), such as those observed after
overexpression [21,22], or others identified as multivesicular
bodies (MVBs) [16,21]. Intracellular localisation of TLR3 appears
to be crucial for its activation [23,24]. In neuronal cells, TLR3 is
mainly intracellular [16–18]. However, the precise intracellular
localisation of TLR3 in neuronal cells is largely unknown.
Rabies virus (RABV) almost exclusively infects neurons, where
it triggers interferon, inflammatory and antiviral responses [17,25].
The virus particle binds cell-surface receptors and follows the
endosomal pathway, allowing the release of viral nucleocapsid
(NC) into the cytoplasm. The life cycle of the virus then progresses
in the cytoplasm, with transcription of the five N, M, P G and L
viral genes and the replication of negative- and positive-polarity
genomes [19,26]. Moreover, RABV infection induces the
formation of cytosolic protein aggregates called Negri Bodies
(NBs). NBs are characterized by the accumulation of viral NC
proteins [27–29]; they also contain endothelial nitric oxide
synthase (eNOS) [30]. NBs resemble inclusion bodies and/or
aggresomes seen in several neurodegenerative disorders [31].
Aggresomes are defined as pericentriolar cytoplasmic inclusions
resulting from the aggregation of misfolded and/or ubiquitinated
proteins [32,33]. The aggresomal subcellular compartment
sequesters proteins produced in excess following a cellular stress
such as a viral infection. These proteins are then targeted to
proteasomes and/or autophagy components present in this area.
Some viruses may use aggresomes to enhance replication [34,35].
In this study, we further analysed the production, function and
spatiotemporal location of neuronal TLR3, and notably its
association to the endosomal compartment. We carried out these
studies either in cultures of human neuronal cells (neuronal
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blastoma cell line SK-N-SH) or in TLR3
2/2 mice using the
pathogenic RABV strain CVS.
Results
Human Ntera-2clD/1, SK-N-SH, and NT2-N cells express a
full-length TLR3 whose expression is not altered by RABV
infection
Human post-mitotic neurons (NT2-N) produce several TLRs,
including TLR3 [17,19]. TLR3 mRNA levels were analysed by
semi-quantitative RT-PCR in the neuronal precursors Ntera-
2clD/1, from which NT-2N cells are derived, and in a human
neuroblastoma cell line (SK-N-SH). An amplified product of
527 bp was detected in the three types of neuronal cells
(Figure 1A). We then sequenced the whole TLR3-encoding gene
open reading frame by direct sequencing. We found that human
neuronal TLR3 sequence from NT2-N (sequence ID: DQ445682)
was strictly identical to those previously identified in other human
cells (GenBank accession: NM_003265). These findings strongly
suggest that TLR3 in neuronal cells could be functional. Yang et al.
reported the existence of a TLR3 isoform in primary human
astrocytes and glioblastoma [36]. This isoform is produced by
deletion of an intron-like sequence within exon IV of the gene and
is co-produced with wild-type TLR3. The presence of this isoform
in Ntera-2clD/1, U373MG (astrocytoma) and CHME (microglia)
was tested by semi-quantitative RT-PCR experiments using pairs
of primers spanning the intron-like sequence in exon IV (Figure 1B,
upper gel). This isoform was not detected in the three cell lines
tested. Moreover, no quasi-species of wild-type transcripts or
transcripts with deleted sequences were observed after RABV
infection of SK-N-SH neuroblastoma (Figure 1B, lower gel).
The effect of infection on TLR3 levels was monitored by
immunoblotting using two distinct antibodies (Ab) directed against
the NH2 terminal of the TLR3 ectodomain (sc-Q18 and IMG-315A).
Cellular extracts were prepared from Ntera-2clD/1, either non-
infected (NI) or infected with RABV for 12, 24 or 48 h. We detected a
100 kDa band corresponding to full size TLR3 protein in all cell
extracts (Figure 1C data shown for IMG-315A Ab). The amount of
neuronal TLR3 was not affected by RABV infection even 48 h after
infection (Figure 1C). These results were consistent with those
obtained by cytofluorimetry (two upper right panels of Figure 1D,
data shown for Sc-Q18 Ab), with no difference in proportion of cells
displaying fluorescently labelled total TLR3 observed between NI and
infected Ntera-2clD/1 cells (40 and 39% respectively). In experiments
performed without cell permeabilisation (surface fluorescence), TLR3
was not detected at the surface of NI or infected cells (lower right
panels of Figure 1D). Thus, TLR3 is not expressed at the surface, at
least at detectable levels, and infection does not cause TLR3 to
relocate towards the cell surface. Similar findings were obtained with
the SK-N-SH neuroblastoma (data not shown).
These data indicate that human neuronal cells produce full-
length TLR3; this protein was not upregulated by RABV infection
and had an intracellular localisation in both NI and infected cells.
TLR3 has a canonical endosomal localisation in human
neuronal cells
Intracellular localisation of TLR3 was further investigated in
Ntera-2clD/1cells by immunocytochemistry and confocal micros-
copy. In the absence of infection, TLR3 was found within small
vesicles throughout the cytoplasm. Co-immunocytochemistry anal-
ysis using Ab directed against the NH2 terminal of TLR3 (Sc-Q18)
and against either CD63, a marker of late endosomes and/or
multivesicular bodies (left panels of Figure 2A), or a marker of early
endosome (EEA1) (upper panels of Figure 2B) revealed that a
proportion of TLR3 was associated with endosomes, mainly in late
endosomal vesicles (colocalisation index of 0.55 and 0.86 for early
and late endosomal markers, respectively; Figure 2C). A small
proportion of TLR3 was found associated with Golgi (GM130) and
with the endoplasmic reticulum, ER (calnexin) (data not shown).
Thus, in neuronal cells, TLR3 protein was located mainly
within the early/late endosomal compartment.
As well as its endosomal localisation, TLR3 targets large
perinuclear aggregates in RABV–infected cells
Two days after RABV infection, the endosomal distribution of
TLR3 was conserved (as shown in Figure 2A, left panel, and
Figure 2B, lower panel). However, colocalisation coefficients between
TLR3 and CD63 were slightly lower in RABV-infected than in NI
cells (0.86 and 0.79 for NI and RABV-infected cells, respectively). This
decrease may result from the appearance of a new site of TLR3
intracellular localisation. TLR3 became concentrated in large
perinuclear aggregates in RABV-infected cells (arrow heads in
Figure 2A and 2B). This observation was reproduced using three
distinct TLR3-specific Ab (Sc-Q18, Sc-C20 and FITC-conjugated Ab
IMG-315C)and in cultures of NT2-N (Figure S1) and SK-N-SH (data
not shown). Perinuclear aggregates were not stained by anti-CD63 or
anti-EEA1 Ab, or by OKT9, a marker of recycling endosomes. This
suggests that the RABV-induced aggregates were distinct from the
endosomal compartment. RABV-induced TLR3 aggregates were not
associated with Golgi (GM130) or the ER (calnexin) (data not shown).
This aggregation of TLR3 was not observed when cells were infected
with herpes simplex virus type 1 or Sendai virus, or when cells were
treated for 24 h with rIFN–b (500 IU/ml) (data not shown).
These observations suggest that RABV triggers perinuclear
aggregation of TLR3, distinct from the endosomal compartment.
TLR3 proteins are associated with RABV N and P proteins
in perinuclear inclusions formed by an inner TLR3 core
coated with viral proteins
Confocal microscopy analysis of RABV-infected cells co-stained
with Ab directed against TLR3 and RABV nucleocapsid NC
Author Summary
Viruses are obligate parasites. The progression of their life
cycle depends on their hijacking the cellular metabolism
and machinery. Human neurons produce TLR3, a protein
involved in early host defence mechanisms and the
modulation of neuronal survival. Rabies virus is a
neurotropic virus, infecting mainly neurons. In this study,
we showed that rabies virus exploits TLR3 function to store
viral proteins and viral genomic material in particular areas
of the cell where virus multiplication occurs. We found
that, during the course of infection, large (1–3 mm)
spherical inclusions were formed within the region around
the nucleus. These inclusions were composed of an inner
core of aggregated TLR3 surrounded by a coat of viral
proteins and genomic material. These inclusions were
revealed to be the previously described Negri Bodies (NBs).
In absence of TLR3, NBs were no longer formed and virus
multiplication rate decreased. Mice deficient in TLR3 were
more resistant to rabies and had lower levels of infection in
their brains. This study shows how neurotropic viruses,
such as rabies virus, hijack normal functions of neuronal
proteins and use cell compartmentalisation to promote
viral multiplication.
Virus-Driven TLR3 Hijacking
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the great majority displaying the same localisation pattern as TLR3-
containing aggregates (Figure 3A, TLR3 in red, NC in green,). Viral
NC(comprisingN,P,Lproteinsandthe viralRNAgenome)seemed
to form a ring around a TLR3 core. TLR3-positive inclusions were
further analysed by confocal microscopy (Figure 3B) and imaging
(Figure 3C). Modelling of deconvoluted confocal images with 3D
ImarisH software confirmed the particular spatial organisation of
TLR3/NC aggregates (Figure 3C). The reconstruction of images of
a typical 48 h TLR3/NC aggregate is shown in Figure 3B. The
round-shaped perinuclear structure has a total diameter of 3.0 mm
with an NC coating 0.5 mm thick. TLR3/NC aggregates were also
observed using monoclonal antibody (mAb) specific for viral P or N
protein, confirming that the main protein constituents of NC were
present in the aggregates (Figure 4A). In contrast, immunocyto-
chemistry performed with a mAb directed against the RABV G
protein — associated with the RE or Golgi vesicles in the cells —
showed that TLR3 aggregates were not associated with RABV G
protein (Figure 4B). Co-immunoprecipitation performed with Ab
directed against NC and TLR3 (Q18 and C20 Ab) gave negative
results (data not shown), suggesting that interactions between TLR3
and viral NC were either weak or indirect.
The kinetics of RABV NC aggregate formation were analysed
in Ntera-2clD/1 at 12, 24 and 48 h post-infection (pi) and stained
Figure 1. Expression of TLR3 in non-infected and RABV–infected neuronal cells. (A) Neuronal precursors (Ntera-2clD/1), human post-
mitotic neurons (NT2-N), and neuroblastoma cells (SK-N-SH) express TLR3 transcripts (size 527 bp), as shown by RT–PCR. 18S was used as a reporter
gene. (B) RT–PCR was performed with a pair of primers corresponding to exon 4 of TLR3. The amplified fragments from Ntera-2clD/1, astrocytes (U373
MG), microglia (CHME) (upper panel), or SK-N-SH (lower panel) were a similar size (345 bp), suggesting that TLR3 does not undergo alternative
splicing in these neural cell types. Alternative splicing was not observed during infection, monitored by viral N protein (N) transcription (lower panel).
M denotes molecular weight. (C) TLR3 protein was detected in RIPA lysates of non-infected (NI) and RABV–infected Ntera-2clD/1 cells using a mAb
(cloneIMG315-A) directed to the NH2 terminal of TLR3. Infection was monitored by detection of the viral N (N) and P (P) proteins. TLR3 protein
(102 kD) was not upregulated by infection, as shown by quantification of TLR3 (histogram) using calnexin (Cx) as a standard (GeneTools, Syngene).
The same results were obtained for proteins extracted using Phosphosafe extraction buffer. Graph was generated using GraphPad Prism. (D)
Cytofluorimetry analysis showed that TLR3 has an intracellular location and cannot be detected at the surface of SK-N-SH cells. This distribution
pattern was not modified by infection. The viral nucleocapsid (NC)—left panels—is strictly intracellular, and its detection was thus used as a control
for membrane impermeability. The solid line corresponds to RABV–infected cells and the histogram to NI cells. TLR3 protein (right panels) was
analysed by flow cytometry using a polyclonal antibody directed to the NH2 terminal of TLR3 (Sc-Q18) in NI and RABV–infected cells. Histograms
correspond to secondary Ab and solid lines to TLR3 staining. Numbers represent the percentages of cells positive for TLR3 or NC proteins. These
results are representative of at least 5 separate experiments.
doi:10.1371/journal.ppat.1000315.g001
Virus-Driven TLR3 Hijacking
PLoS Pathogens | www.plospathogens.org 3 February 2009 | Volume 5 | Issue 2 | e1000315with anti-NC Ab (Figure 4C). NC aggregates were detected as
early as 12 h pi, with an average diameter of 1.0 mm (Figure 4E).
The size of aggregates increased as infection progressed, reaching
an average size of 3.0 mm by 48 h pi (Figure 4D, left panel).
Number of inclusions per cell was analyzed by Acapella software
in 24 h RABV-infected SK-N-SH cells (Figure 4D, right panel).
Majority of cells harbour one or two perinuclear TLR3 aggregates
24 h after infection. Later in the infection (48 h after infection and
thereafter), the average number of inclusions per cell increases (as
described below), suggesting that NB formation is a highly
dynamic process.
These observations suggest that RABV triggers formation of
perinuclear TLR3 aggregates -surrounded by a halo of viral N and P
proteins- which number and size are modulated during infection.
TLR3/NC aggregates contain the RABV viral genome and
are Negri Bodies (NBs)
TLR3 has been described for its ability to bind viral RNA. We
carried out hybridisation experiments using a fluorescent probe
specific for the RABV genome leader sequence to determine
whether the TLR3/NC aggregates contained viral RNA (Figure 5).
Wedidnot detect fluorescenceinthe absenceofprobe(Figure 5B)or
in NI cells (Figure 5D). The fluorescent probe stained perinuclear
structures (Figure 5A–5C), corresponding to TLR3/NC aggregates,
forming discrete ovoid structures visible in transmission images, as
described above (Figure 3). Intensity of fluorescence was variable,
suggesting that accessibility of the viral RNA may differ among
aggregates.Theseobservationsshowthat TLR3/NCaggregatesalso
contain RABV genomic material. Immunocytochemistry experi-
ment using J2 mAb specifically recognizing dsRNA [37,38,39]—
including endogenous cellular dsRNA [40,41]—revealed accumu-
lation of dsRNAs in NBs (Figure S2).
The presence of viral N and P proteins and genomic material
within the aggregates suggests that they could be NBs. NBs are
found both in the neurons of rabid brain and in vitro in RABV-
infected neuronal cells, in the form of accumulated viral material
around the nucleus. Electron microscopy analysis of ultra-thin
sections of SK-N-SH 48 h after RABV infection showed that
amorphous aggregates (usually one or two per cell), with an
average diameter of 3.0 mm and without a membrane, were
indeed present and displayed perinuclear localisation (Figure 5E).
We did not find such aggregates in NI cells (data not shown). We
used electron microscopy to analyse cells treated with Triton X-
100 (0.1%) and stained with Ab directed against NC or TLR3;
cellular structures were not preserved. Aggregates were strongly
stained (DAB accumulation) with both Ab, indicating they
contained both TLR3 and RABV NC proteins (Figure S3).
Figure 2. TLR3 partially colocalises with the endosomal compartment of non-infected and RABV–infected Ntera-2clD/1 cells and
relocates into perinuclear aggregates after RABV infection. Co-immunostaining of TLR3 (Ab sc-Q18, green) with late (A) and early (B)
endosomal compartments using anti-CD63 and anti-EEA1 Ab (red), respectively, in non-infected (NI) (A: left panels, B: upper panels) and RABV-
infected (A: right panels ; B: lower panels) Ntera-2clD/1cells. Nuclei are stained with Hoechst. TLR3 colocalises with CD63 in NI (A, Merge left, arrow)
and in RABV–infected cells (A, Merge right, arrow). TLR3 protein additionally forms perinuclear aggregates that do not contain endosomal markers (A
and B, arrowheads). Images were acquired using a Zeiss LSM 510 META confocal microscope. Projection of 8–10 confocal images is shown.
Bars=10 mm. (C) Colocalisation of TLR3 with endosomal markers: correlation diagrams and Pearson’s correlation coefficients (Rcoloc) are shown: TLR3
(Y axis) with either EEA1 (1) or CD63 (2 and 3) (X axis) are shown for NI (1–2) and RABV–infected cells (3). TLR3 shows very little association with the
early endosomal compartment (1), but is strongly associated with the late endosomal marker in the absence of infection (2). Colocalisation with the
late endosomal marker decreases following RABV infection (3).
doi:10.1371/journal.ppat.1000315.g002
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in particular cell areas characterised by the accumulation of
surrounding mitochondria (M), rough endoplasmic reticulum
(rER) and, in some cells, ‘nests’ of viral particles (Figure 5F). These
areas, with their particular composition resembled the viral factories
previously described for other viruses. Thus, TLR3/NC aggregates
may function as a storage or construction area for viral NC.
Overall, these observations suggest that TLR3/NC aggregates
observed in RABV-infected neuronal cells correspond to previ-
ously described NBs.
Are NBs virus-induced aggresomes?
Due to their perinuclear localisation, size and protein
composition, it is possible that NBs represented virus-mediated
aggresomes. Aggresomes are associated with molecular chaper-
ones such as Hsp70 and surrounded by a cage of cytoskeleton
proteins such as vimentin and a-tubulin [32,33,42]. Thus, we
studied the presence of aggresome characteristics in NBs.
Examination of the distribution of a-tubulin and vimentin in
RABV-infected cells revealed that a ring of a-tubulin indeed
surrounded the NC-positive aggregates (Figure 6A, 1–3). Howev-
er, vimentin was not closely associated with NBs (Figure 6A, 4–6).
The chaperone Hsp70 was present at the periphery of the NBs
(Figure 6B). Aggresomes are often formed at the microtubule
organising centre (MTOC), which can be visualised using Ab
directed against c-tubulin [43]. Double staining of MTOC and
NC proteins clearly demonstrated that NBs are not localized at the
MTOC (Figure 6C).
When cells are lysed in the presence of detergent, aggresomes
are retained in the insoluble (IS) fraction, together with
cytoskeletal proteins such as vimentin, whereas proteins in the
cytoplasm or associated with the ER — such as calnexin — appear
in the soluble (S) fraction. S and IS fractions were prepared from
Ntera-2clD/1 cells infected with RABV for 48 h, and were
separated by SDS-PAGE. The IS fraction prepared from RABV-
infected cells did not contain calnexin or a-tubulin. These proteins
were present in the S fraction, as expected, with the IS fraction
containing vimentin (Figure 6D, upper). Immunostaining revealed
discrete NBs (positively stained for both RABV NC and TLR3) in
the IS fraction (Figure 6D, lower), indicating that NBs are
detergent-resistant structures.
Given the major role of microtubules in the formation of
aggresomes, we analysed their role in the formation of NBs. We
treated RABV-infected SK-N-SH cells (24 h pi) with colcemid
(Figure 7A) — an inhibitor of microtubule polymerisation —
diluted in PBS vehicle, or with vehicle alone or without any
reagent. Effect of colcemid on size and number of NBs per cell was
analyzed 24 h post treatment -corresponding to 48 h post
infection- (Figure 7B and 7C). As shown in Figure 7B, colcemid
treatment modified the size of NBs. Overall, in colcemid-treated
cells there are more cells with large NB (range between 200 and
350 pixels) than cells exhibiting small NB (range 50 to 150 pixels).
Figure 3. TLR3 and viral NC proteins are assembled in spherical perinuclear structures. (A) RABV-infected Ntera-2clD/1 cells were co-
stained with Ab directed against the viral nucleocapsid (NC green), TLR3 (Ab Sc-C20, red), and Hoechst (nuclei, blue). In all infected cells TLR3–positive
aggregates colocalize with viral NC forming perinuclear structures (Merge, lower panel). Bar=10 mm. (B) RABV-infected Ntera-2clD/1 cells were co-
stained with Ab directed against the viral nucleocapsid (NC green), TLR3 (Ab Sc-C20, red), and Hoechst (nuclei in blue). T is the transmission picture.
The merged picture shows that NC accumulates with some perinuclear TLR3–positive aggregates (arrow). These perinuclear aggregates are visible in
the transmission image. M is the 3D rendering (Imaris, Bitplane AG) after deconvolution (Huygens, Scientific Volume, Imaging). TLR3 constitutes the
core of the structure (red internal core), surrounded by a coating of viral NC (green halo). Nuclear material was not present in these structures.
Bar=5 mm. (C) Enlargement of a 3D rendering of a TLR3–containing aggregate, showing the typical organisation of RABV–induced inclusions bodies
composed of an inner core (TLR3 in red) surrounded by a viral NC protein cage (green halo). Diameter of the aggregate is 2.7 mm.
doi:10.1371/journal.ppat.1000315.g003
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distribution of NB per cell (Figure 7C). In absence of treatment,
24 h after infection RABV-infected cells harboured 2 or 3 NBs per
cell (as shown in Figure 4D). This number rises up to more than 7–
8 NBs per cell 48 h after infection (Figure 7C). Colcemid
treatment blocks this increase since colcemid treated cells have
less NBs per cell than non-treated cells. These observations
indicate that microtubule polymerisation play a role in the
dynamic of NBs particularly after their formation, as suggested
by the increase in number of NBs per cell between 24 and 48 h pi.
These data support a role of microtubules in the outcome of NBs.
NBs from cells treated with colcemid were twice as small as those
from cells treated with vehicle alone (Figure 7B), supporting a role
for microtubules in NB formation.
Overall, our findings showed that NBs are resistant to detergent,
involve microtubules in their outcome and are surrounded by the
cellular a-tubulin and chaperone network. These features are
reminiscent of aggresomes. However, NBs were not associated to
the MTOC and not surrounded by a vimentin ‘cage’. Thus, they
do not represent canonical aggresome structures.
TLR3 is necessary for the formation of NBs
TLR3 was found at the centre of NBs. Thus, we analysed the
involvement of TLR3 in the formation of NBs in TLR3 silencing
experiments. Plasmids encoding emerald GFP and miRNA
targeting the TLR3 gene (miTLR3) were delivered by nucleofec-
tion (Amaxa program Q-001) into Hek293A Qbiogene cells. Non-
specific miRNA (miNEG) was used as a control. Nucleofection
efficiency ($90%) was controlled using a plasmid encoding the
GFP protein (provided by the Cell Nucleofector Kit V, Amaxa).
Cells were infected with RABV 24 h after nucleofection. 48 h pi,
RNA was extracted or cells analysed by immunocytochemistry.
TLR3 mRNA levels were compared between miTLR3 and
miNEG cultures. As shown in the left panel of Figure 8A, the level
of TLR3 mRNAs was decreased by 60% in miTLR3 compared to
miNEG cells. Cytofluorimetry analysis of TLR3 (sc-Q18 Ab)
stained cells showed that these reduced mRNA levels were
associated with a reduced intensity of fluorescence (Figure 8A,
right panel), indicative of reduced TLR3 protein production in
miTLR3 cultures. Moreover, the reduced TLR3 levels were
accompanied by a 10-fold reduction of viral transcription
Figure 4. RABV–induced inclusion bodies correspond to Negri Bodies (NBs). They contain viral N and P, but not G. (A) Immunostaining of
RABV P protein (P) and N protein (N) using specific Ab shows the colocalisation of the two proteins within the NBs (merge+nuclei) (B) RABV–induced
aggregates (NC, green) do not contain RABV G protein (G, red). Bar=10 mm. (C–D) Ntera-2clD/1 cells were infected with RABV, fixed with PFA, and
stained with an Ab directed against NC 12, 24, and 48 h pi. (C) Small perinuclear aggregates are detected as early as 12 h pi and their size increases
with time. (D, left panel) Size of aggregates increase as the infection progress from a 1 mm diameter 12 h pi up to 3.0 mm 48 h pi. In this experiment,
viral NB diameters were measured manually using the Leica FW 4000 software. Graph represents means with SEM. (D, right panel) 24 h after pi
majority of cells contains 1–3 NBs. Viral NB were quantified by Acapella Software.
doi:10.1371/journal.ppat.1000315.g004
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by cytofluorimetry (Figure 8A, right panel), with N protein present
in 77% of miNEG cells and 59% of miTLR3 RABV-infected cells.
Transitory nucleofected cells with the miTLR3 and miNEG
vectors expressing emerald-GFP were assayed for expression of
Em-GFP fluorescence by FACS (data not shown) and immuno-
cytochemistry (Figure 8C), showing that the intensity of Em-GFP
fluorescence is not homogenous among cells in the same
population. Similar data were obtained on stable cell lines selected
for resistance to blasticidin which all possess the expression
plasmid but nevertheless exhibit a heterogenous Em-GFP
fluorescence (data not shown). Cells were immunostained with
anti-TLR3 (red) and anti-N-RABV mAb (blue) showing that the
miTLR3 population of cells exhibits some TLR3-negative cells
(Figure 8C, lower panel) in contrast to the miNEG population
(Figure 8C, upper panel). In the TLR3-negative cells, NB
formation is abolished. Immunocytochemistry analysis of individ-
ual cells (such as the green GFP cell on the right in Figure 8D)
revealed that NBs — stained red for TLR3 and blue for RABV N
protein — were not present in miTLR3 cells. These observations
strongly suggest that TLR3 is required for NB formation and
RABV N expression. To determine whether the cytoplasmic
domain of the TLR3 protein encompassing the signalling TIR
domain was involved in NB formation, we stable transfected HEK
cells with a plasmid encoding a TLR3 gene with a deleted
cytoplasmic domain (pZero-hTLR3-HA). Cells transfected with
the pZERO-hTLR3 plasmid are therefore unable to signal via
TLR3 because the absence of the TIR domain does not allow
binding of TRIF to TLR3. As shown in Figure S4B, NBs were still
formed and viral transcription was not modified in pZERO-
hTLR3-expressing cells (transitory experiments). Similar data were
obtained with stably transfected cell lines selected for their
resistance to puromycin (data shown in Figure S4 are represen-
tative of both conditions). Furthermore, the adaptor TRIF could
not be detected in NBs (Figure 4C), suggesting that activated
TLR3 molecules were not present in NBs.
Thus, the ectodomain of TLR3 appears to be crucial for the
formation of NBs. TLR3 may therefore favour virus multiplication.
TLR3
2/2 mice have reduced susceptibility to rabies
Assuming that TLR3-NBs are required for virus multiplication,
we would expect RABV infection to be impaired in the brain of
TLR3-deficient mice (TLR3
2/2) and subsequently these mice
would be expected to have a higher survival rate than WT mice.
We compared the progression and outcome of RABV infection in
TLR3
2/2 with WT mice. TLR3
2/2 (n=9) and control WT
Figure 5. NBs contain viral genomic material, suggesting they are specialized sites for viral multiplication. Aggregates contain RABV
genomic material. RABV–infected (A–C) and non-infected (D) BSR cells were incubated with (A, C, D) or without (B) fluorescein-conjugated RNA
probes specific for the viral RABV genome. Both fluorescent (upper panels) and transmission images (lower panels) were shown for each condition.
(A) Genomic material was detected in the discrete aggregates (arrows) located around the nuclei (N) of RABV–infected cells. (B) No fluorescence is
seen in RABV–infected cells in the absence of RNA probes. These pictures were acquired with a Leica DM5000B fluorescence microscope. (C) Detail of
a RABV–infected single cell with the anti-genomic probe (confocal stack). (D) No fluorescence was detected in non-infected cells incubated with the
fluorescein-conjugated RNA probes. Bars (A–D)=10 mm. (E and F) Neuroblastoma SK-N-SH cells were infected for 48 h with RABV, fixed and prepared
for electron microscopy analysis. (E) Electron microscopy of a section showing that aggregates are located near the nucleus (N) surrounded by
mitochondria (M) and rough endoplasmic reticulum (rER). Aggregates are not limited by a membrane. B.w=base of culture well. C.m=culture
medium. (F) Viral inclusions are seen close to the sites of viral assembly. Nests of virus particles (arrow) are located close to viral NBs and rER.
Bars=2 mm.
doi:10.1371/journal.ppat.1000315.g005
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kill 3/4 of the mice. Mice were observed for 15 days post infection.
At day 13 pi, only 37% of the WT mice were alive, whereas 66%
of the TLR3
2/2 mice survived (Figure 9A). Progression of the
disease in the two groups of mice is illustrated by the cumulative
clinical curves (Figure 9B). Clinical score was significantly
decreased in TLR3
2/2 mice compared to WT mice. Finally
RABV neuroinvasiveness was compared in these mice by
measuring the amount of RABV genome in the brain of RABV-
infected WT and TLR3
2/2 mice at day 11. Levels in NI brain
were given a reference value of 1, for calibration. RABV genome
level in TLR3
2/2 brain was markedly lower than in WT mice (20
times lower) (Figure 9C). All together, these strongly support a role
of TLR3 in RABV infection.
Discussion
Our study demonstrates that TLR3 is localised in the cytoplasm
of non-infected neuronal cells, where it is associated mainly with
the endosomal compartment. TLR3 subcellular localisation is
notably altered by RABV infection, with TLR3 found within viral-
induced inclusions identified as RABV-induced Negri Bodies
(NBs). The presence of TLR3 in the core of viral NBs, surrounded
by a ring of viral N and P proteins, appears to be crucial for NB
formation. This finding demonstrates a novel function of TLR3, a
molecule mostly known for its immune functions.
In the absence of infection, reactivity with anti-CD63 antibody
and weak signal from EEIA-expressing early endosomal structures
showed neuronal TLR3 to be confined to the endosomal
compartment, associated mainly to the late endosomes and
multivesicular bodies. TLR3 is rarely detectable within the Golgi
apparatus or at the endoplasmic reticulum. Indeed, we observed
the canonical distribution pattern of TLR3 in human non-infected
neuronal cells, as previously described for human DCs or
fibroblasts [21,22].
The subcellular distribution of TLR3 is markedly altered in
RABV-infected cells, being localised in perinuclear inclusion bodies,
the NBs. These NBs contain viral NC but do not include the
envelope viral proteins [27]. Relocation of TLR3 during viral
infection has only previously been described for respiratory syncitial
virus (RSV). In epithelial cells, RSV infection increases the TLR3
levels and targets TLR3 to the membrane [44]. In neuronal cells,
RABV infection did not increase TLR3 protein levels, or target
TLR3 to the membrane. Given that RABV infection did not
increase the total pool of TLR3 protein, it is possible that the TLR3
is recruited from pre-existing cytoplasmic-, ER- or endosome-
Figure 6. RABV–induced NBs exhibit some characteristics of aggresomes. (A) RABV–infected cells were immunostained with Ab against viral
NC (1 and 4) and co-stained with either anti-pan-tubulin (2 and 3) or anti-vimentin Ab (5 and 6). Merged images are shown in 3 and 6. NBs (arrows)
are associated with tubulin fibres (3); however, in contrast to canonical aggresomes, NBs are not surrounded by a ‘cage’ of the intermediate filament
protein vimentin (6). N=nucleus. Bars=10 mm. (B) RABV–infected cells were co-stained with Abs directed against viral NC (1) and anti Hsp70 (2). NBs
are associated with the chaperone Hsp70, as shown by confocal analysis and 3D modelling [3 is the merged image; 4 is a 3D rendering (ImarisH,
Bitplane AG) after deconvolution (Huygens, Scientific Volume, Imaging) of the perinuclear area (white square) from 3]. Bar=5 mm. (C) NBs (green) are
not formed at the MTOC/centrosome, detected using an antibody directed against c-tubulin (arrows). N=nucleus. Bar=10 mm. (D) RABV–infected
cell lysates were separated after detergent treatment, into soluble (S) and insoluble (IS) fractions. The IS fraction contained the insoluble cytoskeletal
protein vimentin but not tubulin or calnexin (Western Blot, upper panel). The IS fraction also contained NBs, which showed positively with anti-NC
(green) and anti-TLR3 Ab (red). Bars=2 mm.
doi:10.1371/journal.ppat.1000315.g006
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endosomal or ER markers, suggesting that endosome- or ER-
associated TLR3 is not involved in NB formation.
NBs observed by electron microscopy did not reveal the presence
of any membrane surrounding the NBs. Thus, it is unlikely NBs are
autophagolysomes or lysosomes. Confocal microscopy and 3-D
imaging revealed that NBs have a highly organised structure, with a
TLR3-containing core surrounded by a halo of viral N and P
proteins. The central position of TLR3 suggests that NB formation
may be initiated by the aggregation of TLR3 molecules. A
primordial role of TLR3 in NB formation is consistent with the
absenceofNBsfromcellsinwhichTLR3hadbeensilenced.TLR3is
a horseshoe-shaped solenoid with 23 leucine-rich repeats (LRRs)
located in the ectodomain of the molecule. Similarly to other
solenoid proteins including polyQ, TLR3 may have an intrinsic
capacity to form aggregates [45]. NBs formed even in the absence of
the cytoplasmic domain of TLR3, suggesting a major role for the
TLR3ectodomaininNBformation(FigureS4).PolyQproteinssuch
as mutant huntingtin protein form inclusions consisting of an inner
dense core of aggregated huntingtin surrounded by a ring structure
composed of sequestered cellular proteins [46,47]. Experiments
involving the sequential expression of polyQ followed by expression
of these cellular proteins led to the conclusion that the ring structure
results from the subsequent recruitment of cellular proteins at the
exterior surface of an initial polyQ core aggregate. The organisation
of NBs may follow a similar pattern. In this case, NBs would result
from the initial association of TLR3 molecules followed, in a second
step, by the accumulation of viral proteins, forming a ring into which
cellularproteinscould alsobeinserted.Thiswouldbe consistent with
the concentric organisation of NB structure and observation of the
cellular protein eNos is recruited in NBs in RABV-infected brain.
However, the NB structure is distinct from polyQ-initiated
aggregates. In particular, TLR3 in NBs is still accessible to Ab.
This has not been observed for huntingtin. These observations
suggest that the viral ring of protein in NBs is more porous than the
ring surrounding the ordered huntingtin aggregate structure.
Consequently, NB and polyQ aggregates may have distinct
properties. The recruitment and sequestration of cellular proteins
in polyQ aggregates may lead to the functional depletion of cellular
functional proteins, possibly underlying toxic properties of these
aggregates in the cell. This is not necessarily the case for NBs.
The nature of the interaction between TLR3 and viral proteins
in NBs remains unclear, since attempts to coimmunoprecipitate
TLR3 and NC have failed.
NBs mimic aggresomes but do not exhibit the full set of
characteristics of these stress-induced cellular processes. NBs are
associated to the chaperone Hsp70 and to the microtubule network,
reminiscent of the two principle features of aggresomes [48].
However, the marked redistribution of vimentin fibres observed for
example in GFP-250-induced aggresomes, and in Theiler’s or
reovirus-induced aggresome-likeinclusions [49,50] was not observed
in RABV-infected neuronal cells. In contrast to most aggresomes,
Figure 7. Involvement of the microtubule network in NBs dynamics. To analyze the role of microtubules in the NBs outcome, 24 h RABV–
infected SK-N-SH cells were either treated with colcemid (a drug which disrupts microtubule network), with PBS (vehicle), or in the absence of drug
for 24 h. (A) Efficiency of colcemid on microtubules stability was assayed by staining 24 h PBS–treated (upper panels), and colcemid treated cells
(lower panels) with an Ab directed against tubulin (red). Nuclei are stained with DAPI (blue). Bar=10 mm. (B and C) Effect of colcemid on size and
number of NBs per cell in 48 h RABV–infected cells. After fixation, cells were stained with viral NC Ab. Size (units=pixels) and number of viral
inclusions were determined and analysed using Acapella software. Infection levels were similar in presence or in absence of colcemid. (B) Colcemid
treatment modifies the size of NBs in the culture by increasing the number of NBs of intermediary range size (200–350 pixels). (C) Colcemid treatment
interrupts the increase of NBs per cell (.8 NBs/cell) seen 48 h after infection. In absence of treatment 75% of 48 h RABV infected cells contains .8
NBs per cell. This percentage is reduced by one half (35–40%) after a 24 h colcemid treatment. Graphs represent means and SD (standard deviation).
doi:10.1371/journal.ppat.1000315.g007
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associated with the microtubule organising centre (MTOC).
The effect of inhibition of microtubule depolymerisation, by
addition of colcemid, on the distribution and size range of NB may
indicate that microtubules are required for NB outcome. The
finding that NBs do not display all the characteristics of
aggresomes has also been observed for inclusions formed in
African swine fever virus (ASFV), which have been described to
function as ‘‘viral factories’’. Viral factories are areas of cytoplasm
where viral components and cellular components supporting viral
replication are concentrated [51,52]. The possibility that NBs
function as dynamic structures involved in viral multiplication, as
proposed by Lahaye et al. (submitted), is supported by electron
microscopy pictures showing that NBs are found closely associated
with newly synthesised viral particles. TLR3 would thus be an
essential component for virus multiplication. Consistent with this
notion, we showed that NBs were absent from cells with TLR3
silencing and that TLR3
2/2 mice were less severely infected by
RABV than WT mice. Further studies are now required to show
whether RABV production is promoted by TLR3.
A major function of TLR3 is to sense and respond to viral
infection. The presence of TLR3 in the core of NBs can be seen as
an attempt to inactivate TLR3 function. Sequestration of TLR3
into NBs could reduce the cellular innate immune response. The
absence of TRIF –adaptor of TLR3- in NB could support the
hypothesis that TLR3 molecules in NB are inactive-. The presence
of viral RNA in NBs may reflect an interaction of TLR3 with viral
components at an early stage of infection, when the virus enters
the cell through the TLR3 decorated endosomal compartment.
TLR3 could thus be involved in recruitment of viral NC from the
endosomal compartment, before aggregation in NBs. However,
the absence of endosomal markers within the NBs remains
unexplained. In addition, the presence of dsRNAs in NBs may
suggest that NBs can also sequester dsRNAs and thus may play a
role in the innate immune response to RABV infection.
Alternatively, given that TLR3 can trigger neuronal apoptosis
[53], the sequestration of TLR3 could be seen as an attempt of
RABV-infected neuronal cells to escape TLR3-induced apoptosis.
Tanaka et al, 2004 showed an uncoupling of a-synuclein-/
synphilin-1-positive aggregate formation and apoptosis [54]. They
Figure 8. TLR3 is required for the formation of viral NBs. Hek293A cells were nucleofected (Q-001 Amaxa Program) with Emerald-GFP-
plasmids encoding specific miRNA for TLR3 (miTLR3) or control miRNA (miNEG). 24 h post-nucleofection cells were infected or not with RABV. (A)
Efficiency of silencing was assayed at transcriptional level by quantitative PCR (left panel) and at protein level by cytofluorimetry (right panel). TLR3
mRNA levels in miTLR3–treated cells were 60% lower than in miNEG cells. Cytofluorimetry analysis showed that TLR3 levels (shift to the left) in
miTLR3–treated cells were lower than in miNEG cells. The values are representative of at least 3 experiments. (B) TLR3 silencing decreases viral
multiplication. Control cells (miNEG) and TLR3–silenced cells (miTLR3) were assessed for viral genomic material (left panel, Q-PCR) and RABV protein N
levels by flow cytometry (right panel). RABV transcription was decreased by 80% after silencing panel and the percentage of cells producing N was
reduced following TLR3 silencing. (C) The absence of NBs was demonstrated by immunofluorescence. TLR3–silenced cells were immunostained with
anti–TLR3 (Sc-Q18) (red) and anti-viral N protein Ab (blue). Plasmid encodes emerald-GFP (green). NBs were detected in TLR3-positive cells but not in
TLR3–silenced cells as observed in the miTLR3 population. Bars=20 mm. (D) Enlarged area of C panels.
doi:10.1371/journal.ppat.1000315.g008
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promote cell survival rather than cell death. In our model,
sequestration of TLR3 could be a way for the virus to prevent a
TLR3-mediated pro-apoptotic response to infection, as neuronal
integrity is required for RABV propagation though the CNS.
Promotion of neuronal survival and virus replication are not
exclusive and could be complementary strategies. Preliminary
results indicate that RABV strains promoting either neuronal
survival or death display different effects on NB size. Further
experiments will be required to understand the role of NBs in the
control of neuronal death.
In conclusion, these findings describe a novel role for TLR3 and
describe how viruses — in our case, RABV — hijack normal
functions of neuronal proteins and exploit cell compartmentalisa-
tion to favour the progression of their life cycle.
Materials and Methods
Cells and virus
Human Ntera-2clD/1 cells (ATCC CRL, 1973), human SK-N-
SH cells (ATCC HTB11) and Hek293A (QBiogene) were grown
in Dulbecco’s Modified Eagle Medium (DMEM) with Glutamax-I,
high glucose and sodium pyruvate 100 mM (Invitrogen, UK),
supplemented with 10% FCS-N (foetal calf serum for neuronal
cultures, Invitrogen, U.K.), 100 mg/ml streptomycin and 100 U/
ml penicillin (Invitrogen). Human NT2-N cells [55] were
differentiated from Ntera-2clD/1 cells by trans-retinoic acid and
antimitotic treatment as previously described [56,57]. BSR cells (a
clone of BHK21 baby hamster kidney cells) [58] were cultivated in
DMEM supplemented with 8% FCS. Human grade III U373MG
astrocytoma (ATCC HTB 17) cells were propagated in Dulbecco’s
modified essential medium supplemented with 2 mM L-gluta-
mine, 1 mM sodium pyruvate, 5% FCS, 2% sodium bicarbonate,
100 U/ml penicillin, and 100 mg/ml streptomycin at 37uC. The
human microglial cell line CHME was cultivated as previously
described [59]. The laboratory RABV strain CVS (ATCC vr959),
a highly pathogenic strain causing fatal encephalomyelitis in
mouse after intramuscular injection [60], was propagated as
previously described [61]. Cells were infected at a multiplicity of
infection (MOI) of 3 and cultivated for 12, 24 or 48 h at 37uC, in
5% CO2. HSV-1 strain KOS [62] was propagated in U373MG
cells.
Mice
TLR3
2/2 mice were generated as described [2]. Six-week-old
C57Bl6 from Janvier (St. Berthevin, France) or TLR3
2/2 female
mice were inoculated intramuscularly in both hind legs, with
1610
7 infectious particles of RABV. Disease progression was
evaluated by scoring clinical signs and mortality. Mobility and
mortality were scored as follows: 0=normal mice, 1=ruffled fur,
2=one paralysed hind leg, 3=two paralysed hind legs, 4=total
paralysis (defined as the total loss of mobility) and 5=death. Daily
clinical score was obtained by adding individual scores. Dead mice
were reported in the clinical score of the day of the death and
thereafter (cumulative scores). Disease progression was presented
by a curve of cumulative clinical scores. Mortality was scored
daily. Dead mice were counted on the day of death and thereafter
(cumulative score). At day 11 after infection, groups of three mice
were perfused with PBS. Brains were removed separately and
stored at –80uC before being processed for RNA extraction.
Animal housing and experimental protocols followed guidelines
approved by the French Ministry of Agriculture and Ethical
committee.
Antibodies and reagents
Antibodies (Ab) to TLR3 (Q18, C20, H125) and anti-IgG goat
biotinylated Ab were from Santa Cruz Biotechnology (Santa Cruz,
CA, USA). Monoclonal antibodies (mAb) to TLR3 - IMG-315C
(FITC-conjugated, immunostaining: 1/50), IMG-315A (Immuno-
blot: 1/500) and anti-TRIF (1/100) mouse polyclonal were from
Imgenex (California, USA). Hoechst 33342, RIPA buffer,
glutaraldehyde (G-5882), 206 SSC buffer, poly-D lysine and Ab
to vimentin (Cy3 conjugate) (clone V9) and c-tubulin (clone GTU-
Figure 9. Rabies is less severe in TLR3
2/2 mice and neuroinva-
siveness is reduced. Comparison of RABV infection in TLR3
2/2 and
C57Bl6 (WT) mice. (A) Kaplan-Meier survival curves for TLR3
2/2 (gray
curve and circles) and WT (black curve and triangles) mice after
injection of RABV (n=8 WT and n=9 KO mice). Chi-square=2.24 (,3,6)
with a degree of freedom of 1 and a significance of P (0.134). The hazard
ratio was 0.2882. (B) Cumulative clinical scores are significantly different
at P value,0.05. (C) Viral load (RABV genome) was measured by relative
Q-PCR at day 11 pi in the brain of TLR3
2/2 and WT mice (three mice
each). Histogram represents means with SD. P value=0.002. Two
separate experiments were performed.
doi:10.1371/journal.ppat.1000315.g009
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Hsp70 (SPA-810, 1/200) was from Stressgen Bioreagents
(Victoria, BC, Canada). Ab directed against calnexin (clone 37,
1/500) and EEA1 (1/500) were purchased at BD Transduction
Laboratories. Fc Block
TM and CellFIX
TM were from BD
Pharmingen (BD, Franklin Lakes, NJ, USA). KaryoMAXH
ColcemidH Solution in PBS, Alexa FluorH 488-conjugated anti-
IgG rabbit and Alexa FluorH 594-conjugated anti-IgG mouse were
from Invitrogen (Cergy-Pontoise, France); ProLongH Gold Anti-
fade reagent with or without DAPI and Alexa FluorH 594-
conjugated anti-IgG goat were purchased at Molecular Probes
(Eugene, Oregon, USA). R-phycoerythrin-conjugated streptavidin
was purchased from Dako (Trappes, France). Ab against CD63 is
a kind gift from Eric Rubinstein (Inserm 602, Villejuif, France).
Peroxidase-conjugated donkey anti-IgG mouse and AMCA-
conjugated Streptavidin were from Jackson ImmunoResearch
Laboratories (Suffolk, UK). For hybridisation experiments: RNA
storage solution, proteinase K solution, deionised formamide, ultra
pure BSA and yeast tRNA were from Ambion. Mouse mAb
directed against the RABV P protein (721.2), RABV N protein
(PVA-3) or the RABV G protein (PVE-12) have been previously
described [63–65]. FITC-conjugated rabbit anti-RABV NC Ab
and kaleidoscope prestained protein standard (161-0324) were
obtained from Biorad (Marnes-La-Coquette, France). Streptavidin
peroxidase, hybond-P PVDF (PolyVinylidine DiFluoride), bioti-
nylated sheep anti-mouse IgG (RPN1001) and ECL
+ kit were from
GE Healthcare (UK). Micro BCA Protein Assay Reagent was
from Pierce (Rockford, IL, USA). Ab against a-tubulin (clone
DM1A, 1/1000) was from Oncogene Research Products,
PhosphoSafe
TM Extraction Buffer was from Novagen. Fluoro-
mount-G was obtained from Southern Biotechnology (Birming-
ham, AL, USA). IgG2a mAb J2 (1/1000) directed against dsRNA,
of length less than or equal to 40 bp, were obtained from English
and Scientific Consulting Bt, Szirak, Hungary.
RT–PCR, quantitative PCR
Total RNA was isolated from cells using an RNeasy kit (Qiagen,
Germany). cDNA synthesis was performed with 2 mg RNA using
oligo(dT) primers (100 ng). Superscript II reverse transcriptase
(RT) and Taq DNA polymerase (QBiogene) were used for RT-
PCR in a Px2 thermal cycler (Hybaid Corp., USA). 35 cycles of
amplification were performed as follows: 4 min at 94uC, 1 min at
55uC, 1 min at 72uC, 10 min at 72uC, and final cooling.
Ribosomal 18S RNA was used as a housekeeping gene. Primers
used for amplification of the TLR3 and 18S genes were
synthesised by Eurogentec (Belgium), with the following sequences
(59R39): forward-18S: CTTAGAGGGACAAGTGGCG; reverse-
18S: ACGCTGAGCCAGTCAGTGTA; forward-TLR3: GAG-
GCGGGTGTTTTTGAACTAGAA; reverse-TLR3: AAGTCA-
ATTGTCAAAAATAGGCCT. The primer pair used for TLR3
exon IV deletion is (59R39): Forward-exon4-TLR3: CTCCA-
GGGTGTTTTCACGCAATTGG; Reverse-exon4-TLR3: TTC-
AGGTACCTCACATTGAAAAGCC. For quantitative PCR,
specific primers for TLR3 were from QIAGEN (QuantiTect
Primer #QT00007714). For amplification of RABV genome the
following primers were used (59R39): F=GGAATTCTCCG-
GAAGACTGGACCAGCTATGG;R=AGAATTCCCACTCA-
AGCCTAGTGAACGG. Real-time RT-PCR analysis was per-
formed with an ABI Prism 77700 sequence detection system.
Methods and relative quantification of gene expressions were
carried out using the comparative method according to the
manufacturer’s instructions. Sequence of neuronal TLR3 was
determined and assigned the GenBank accession number
DQ445682.
Flow cytometry
RABV-infected and mock-infected NTera2clD/1 cells were
washed once with phosphate-buffered saline (PBS) containing
Ca
2+Mg
2+ (PBS Ca
2+Mg
2+), scraped (Cell Scraper, Corning) and
pelleted in staining buffer (SB) (PBS, 1% inactivated FCS, 0.1%
sodium azide, pH 7.5). Cells were fixed in 4% paraformaldehyde
(PFA)/PBS for 30 min at 4uC, and resuspended in permeabilisation
buffer (PB) (PBS, 1% FCS, 0.1% sodium azide, 0.1% saponin). Cells
were then incubated with FITC-conjugated anti RABV NC Ab for
detection of viral proteins and/or successively incubated with goat
anti-TLR3 Ab (sc-Q18) followed by biotinylated anti-goat IgG Ab
and finallywith R-phycoerythrin-conjugated streptavidin.Cellswere
then washed with PB. For staining of non-fixed cells, cells were
washed with SB instead of PB and fixed in CellFIX
TM (BD
Biosciences, USA). Cytofluorimetry was performed with a FACS-
Calibur
TM (BD Biosciences). Results were analysed using the
CellQuest
TM Pro (BD Biosciences) software.
Colcemid treatment
Cells were mock- or RABV-infected (at MOI 3) and treated or
not at 24 h pi with colcemid (0.4 mg.ml
21) or vehicle alone (PBS).
Cells were fixed at 48 h pi and immunostained for NC and tubulin
proteins. Widefield observation was performed on Zeiss Apotome
and Zeiss Axiovision 4.2 software for image acquisition. Nuclei
were detected by DAPI staining and NB by anti-NC FITC Ab.
Acapella software (PerkinElmer Acapella 2.0 (TM)) was used to
delineate inclusions and measure of size of viral inclusions (area
determined by number of pixels). The attribution of NB in each
cell was computed by defining a region of interest around each
nucleus. A set of negative controls has been used to fix the
Acapella parameters (i.e. threshold or contrast adjustment). The
different characteristics (area, position and number of NB for each
cell) were saved and exported to Excel (Microsoft).
Immunocytochemistry
RABV- and mock-infected cells were washed once with PBS
Ca
2+Mg
2+, fixed with 4% PFA for 30 min at room temperature
(rT), washed again, and treated with gelatin (1% in water) for
5 min at 4uC. The samples were then incubated for 20 min at rT
in 0.3% Triton X-100-PBS and surface IgG receptors were
blocked with a saturating buffer (ST) (2% bovine serum albumin
and 5% FCS in PBS) for 30 min at rT followed by a 10 min
incubation at 4uC with Fc-block (1/50). Viral NC were detected
by incubation with a FITC-conjugated rabbit Ab for 2 h at rT.
Primary and secondary Abs were diluted in ST. For immuno-
staining, cells were incubated with secondary Ab, biotin/
streptavidin, followed by incubation with DAB, resulting in a
brown coloration. Nuclei were stained with Hoechst 33342 for
immunofluorescence analysis or haematoxylin for transmitted light
acquisition. Slides were washed with PBS Ca
2+Mg
2+, using water
for the last wash. Coverslips were mounted in Fluoromount-G
TM
or ProLong Gold Antifade reagent (+/2 DAPI if Hoechst
previously used). Widefield observation was performed on a Leica
DM 5000B UV microscope equipped with a DC 300FX camera
(640 and 663 objectives). Leica FW 4000 software was used for
image acquisition and processing. Confocal images were acquired
using a Zeiss LSM 510 META (version 3.2) on Axiovert 200 M
with a Plan Apochromat 636 and N.A. 1.4 objective. Confocal
stacks were deconvoluted on HuygensH (Scientific Volume,
Imaging, Netherlands) and 3D rendering was carried out using
ImarisH (Bitplane AG, Switzerland) software. Confocal images
were compiled using serial Z-stacks 0.3 mm apart, representing at
least two experiments. Co-localisation of TLR3 and organelle
markers was analysed using the colocalisation finder and threshold
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colocalisation ignoring pixels below the automatic thresholds.
Immunoblotting
RABV- and mock-infected cells were washed once with PBS
Ca
2+Mg
2+. Cells were lysed with PhosphoSafe
TM Extraction or
RIPA buffer. Soluble and insoluble cellular protein fractions were
separated using previously described protocols [33,42]. Lysate
protein was quantified using the Micro BCA Protein Assay
Reagent. Proteins (20 mg) were loaded into a 10% Tris/Glycine
SDS polyacrylamide gel with Kaleidoscope pre-stained standards
(161-0324, Biorad). Proteins were separated and transferred to a
Hybond-P PVDF membrane for 2 h (150 mA), followed by
saturation for 2 h at rT in saturating buffer (PBS-Tween 0.1%-
Milk 5%). Membranes were incubated with primary Ab overnight
at 4uC, washed in PBS-Tween 0.1%, then incubated with
secondary Ab coupled to horseradish peroxidase (1 h at rT).
Membranes were washed again and analysed by chemolumines-
cence using the ECL
+ kit. Signals are acquired with a GBOX
(Syngene) monitored by the Gene Snap (Syngene) software.
Electron microscopy
Confluent RABV-infected or mock-infected SK-N-SH cells
were cultured for 48 h at 37uC, in 5% CO2 on untreated 4 mm
2
square glass coverslips. Cells were fixed for 30 min at 4uCi na
PFA/glutaraldehyde solution. Culture medium was removed and
immediately replaced by fixative solution with 2% freshly
depolymerised PFA + 2% Glutaraldehyde in 0.1 M PBS.
Subsequent treatments were performed at 4uC. Cells were rinsed
three times in PBS and post-fixed for 30 min in 1% osmium
tetroxide in milliQ water and rinsed. They were dehydrated in
graded concentrations of ethanol followed by pure acetone before
being infiltrated with Araldite. The resin was cured for 3 h at
37uC, then 36 h at 61uC. Ultrathin sections were obtained with a
Reichert Ultracut. Sections were counterstained (or not) with
uranyl acetate and lead citrate and observed on a Jeol 1010
electron microscope. Electron microscopy was also performed on
cells fixed in 3% PFA, permeabilised with 0.1% Triton 6100,
incubated with anti-RABV NC or anti-TLR3 (sc-H125) antibodies
and revealed with DAB. Under these conditions, Abs can access
intracellular targets, but cell structures are poorly conserved.
In situ hybridization
Probe was designed to target the leader sequence genome of the
RABV strain SAD B19 (59 ACCAGATCAAAGAAAAAACAGA-
CATTGTCAATTG 39). RNA probe was synthesised by Dharma-
con and a fluorescein molecule was added at the 39 end. RNA
probes were prepared according to Dharmacon’s protocol and kept
in the RNA storage solution. BSR cells were grown on poly-D
lysine-coated slides and infected or not with RABV. Medium was
removed at 36 h pi and cells were fixed for 30 min at 4uC with 4%
PFA in PBS. All steps were carried out in RNAse-free conditions,
except for the last washes. Cells were incubated for 5 min in 0.2 N
HCl,rinsedin26SSCatrTandincubatedfor10 minat37uC with
Proteinase K (20 mg/ml) in PBS. Slides were subjected to two series
of washes in PBS and RNAse free-water, re-incubated for 10 min at
4uC with 4% PFA, dehydrated in graded ethanol solutions (70, 80,
90, 95 and 100%) for 1 min each and air dried. Cells were overlaid
for 1 h at rT with pre-hybridisation solution (4 mM EDTA, 56
SSC, 50% deionised formamide, 100 mg/ml yeast tRNA, 0.5 mg/
ml ultrapure BSA). Slides were then rinsed in 26SSC for 1 min,
drained and dried with a paper towel. Cells were incubated for 3 h
at 55uC with fluorescein-conjugated RNA probe (20 ng/ml) diluted
in hybridisationsolution (46SSC, 50% deionised formamide, 0,1%
SDS, 8% dextran sulphate, 50 mM DTT) or with hybridisation
solution only. Following hybridisation, cells were washed twice at
RTin26SSC and 0.16SSCfor10 min. Slideswere then air-dried
and mounted using ProLongH Antifade (Invitrogen). Samples were
viewed using a Leica DM 5000B UV microscope and Leica TCS
SP5 for confocal analysis.
Silencing
TLR3-specificmiRNAsequencesclonedintopcDNA
TM6.2-GW/
EmGFP-miR were purchased from Invitrogen (U.K.). High purity
plasmid DNA was purified over JetStar columns (Genomed, Bad
Oeyenhausen). For transient transfections, cells were grown to 80%–
90% confluence and nucleofected using the Amaxa system as
follows: HEK293A cells (Qbiogene) (10
6)i n1 0 0mlN u c l e o f e c t o r
solution L (Amaxa) were mixed with 5 mgo ft h eTLR3-specific
miRNA or control (pcDNA
TM6.2-GW/EmGFP-miR-NEG) plas-
mid inacuvette andsubjected toAmaxaprogramQ-001conditions.
Nucleofected cells were grown in supplemented complete DMEM
medium. 24 h post-nucleofection cells were incubated with
blasticidin (5 mg/mL) and infected with RABV (MOI 3). 48 h pi
cells were fixed and stained with the different Ab for further flow
cytometry analysis. Total RNA extraction (RNeasy Kit, Qiagen,
Germany) was also performed to determine the efficiency of
silencing. Cells grown on slides were fixed with PFA 4% for further
staining of TLR3 and viral NC proteins. Calculation of silencing
efficiency was done as follows (cf TechNotes Volume 15(2), Applied
Biosystems): the mean CT were calculated for each condition and for
both the reference gene (18S) and the gene of interest (TLR3). 2
values are calculated: DCT (=mean CT (experimental ie TLR3)-
mean CT (endogenous ie 18S)) and DDCT (=DCT (experimen-
tal)2DCT (negative control)). The percent knockdown is obtained as
follows: %KD=([1–2
2DDCT]*100).
Overexpression of a TLR3 deletion construct
pUno-mcs and pZERO-hTLR3-(deltaTIR) plasmids (Invivogen)
were amplified according to Invivogen protocol and purified using
JetStar kit Plasmid purification MAXI kit (Genomed). DNA was
quantified and plasmids used for nucleofection of Hek293 cells
(Amaxa program Q-001) (5 mg plasmid for 1610
6 cells). 48 h post-
nucleofection cells were infected with RABV and 24 h post-infection
cells were harvested for total RNA extraction. Q-PCR was carried
out as described above. Stable cell lines were established by addition
of selective antibiotics (blasticidin or puromycin) to culture medium;
cells were passaged over several weeks ($5w e e k s ) .
Data analysis
Graphs (Figures 1C, 4D, 7B, 7C, 8A, 8B, 9, S4) and Student’s T
tests (Figures 4D left, 7B, 7C, 9, S4) were generated and performed
using GraphPad Prism version 5.00 for Windows (GraphPad
Software, San Diego California USA,). For mice experiments,
collected data were plotted for comparison of Kaplan-Meier
survival curves and statistical analysis was performed with
MedCalc software.
Supporting Information
Figure S1 TLR3 protein in NT2-N. Intracellular localisation of
TLR3 in human post-mitotic neuron (NT2-N) cells. NI and
RABV-infected NT2-N were immunostained with TLR3 and NC
Abs. In the absence of infection (NI), TLR3 is localised in small
vesicles throughout the cytoplasm. In RABV-infected cells, TLR3
and viral NC proteins are assembled in well-defined ovoid
cytoplasmic structures (arrow). N=nuclei. Bars=5 mm.
Found at: doi:10.1371/journal.ppat.1000315.s001 (1.50 MB TIF)
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NBs. Intracellular detection of dsRNA was assessed using J2 Ab
(red) in non-infected (NI, upper panels) and RABV-infected SK-N-
SH (lower panels). NBs are detected with anti viral NC Ab (24 h
pi). dsRNA are found in both NI and RABV-infected cells and
within the viral NBs, mainly in the corona.
Found at: doi:10.1371/journal.ppat.1000315.s002 (1.71 MB TIF)
Figure S3 NBs are TLR3/NC aggregates. Electron microscopy
section of 48h-RABV infected SK-N-SH showing typical NBs
containing viral NC (A) and TLR3 (B) proteins. NB=Negri
Bodies. B.w=base of culture well. C.m=culture medium.
Bars=5 mm in A and 2 mmi nB .
Found at: doi:10.1371/journal.ppat.1000315.s003 (1.70 MB TIF)
Figure S4 TIR is dispensable for NBs formation. TRIF - TLR3
adaptor - cannot be detected in NBs. (A) Overexpression of a TIR-
deleted form of TLR3 (encoded by the pZERO-hTLR3-HA
plasmid from Invivogen) was assessed by RT Q-PCR (left panel) in
Hek293A cells. An average fold increase of 25 for TLR3 mRNA in
cells transfected with pZERO plasmid was obtained compared to
cells transfected with empty vector. Graph represents means and
SD. (B) Overexpression of a deleted form of TLR3 does not
modify the formation of viral NBs (arrows) as shown by
immunostaining of cells expressing pZERO vector (right images)
in comparison of cells with empty vector (left images). TLR3 was
detected using Q18 Ab (red) and RABV using anti-NC Ab (FITC,
green). Nuclei (blue) were stained with DAPI. Bar=10 mm. (C)
Immunostaining of RABV-infected SK-N-SH with an anti-TRIF
(green), an anti- RABV P protein (red) Ab and Hoechst (Nuclei,
blue) revealed that TRIF is not located within viral NBs.
Bar=5 mm.
Found at: doi:10.1371/journal.ppat.1000315.s004 (1.10 MB TIF)
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